10yearsTDM-1(Ado-trastuzumabemtansine)LVEFmonitoringTaxanesIntermediate(11-25)Percentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)ChemoendocrinetherapyCapecitabineAromataseinhibitorsEverymonth2yearsVenlafaxineExemestaneTNBCPertuzumab1yearTC (docetaxel /cyclophosphamide)LoperamideprophylaxisOlaparibPembrolizumabTamoxifenRadiationtherapyAbemaciclibAnthracyclines10yearsTDM-1(Ado-trastuzumabemtansine)LVEFmonitoringTaxanesIntermediate(11-25)Percentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)ChemoendocrinetherapyCapecitabineAromataseinhibitorsEverymonth2yearsVenlafaxineExemestaneTNBCPertuzumab1yearTC (docetaxel /cyclophosphamide)LoperamideprophylaxisOlaparibPembrolizumabTamoxifenRadiationtherapyAbemaciclibAnthracyclines

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. 10 years
  2. TDM-1 (Ado-trastuzumab emtansine)
  3. LVEF monitoring
  4. Taxanes
  5. Intermediate (11-25)
  6. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  7. Chemoendocrine therapy
  8. Capecitabine
  9. Aromatase inhibitors
  10. Every month
  11. 2 years
  12. Venlafaxine
  13. Exemestane
  14. TNBC
  15. Pertuzumab
  16. 1 year
  17. TC (docetaxel / cyclophosphamide)
  18. Loperamide prophylaxis
  19. Olaparib
  20. Pembrolizumab
  21. Tamoxifen
  22. Radiation therapy
  23. Abemaciclib
  24. Anthracyclines